Hu Xi-chun, GU Shi-yang, ZU Jian. Association between the 21-Gene Recurrence Score Assay and Risk of Locoregional Recurrence in Node-Negative, Estrogen Receptor-Positive Breast Cancer[J]. Journal of Evidence-Based Medicine, 2010, 10(2): 77-79. DOI: 10.3969/j.issn.1671-5144.2010.02.010
|
Citation:
|
Hu Xi-chun, GU Shi-yang, ZU Jian. Association between the 21-Gene Recurrence Score Assay and Risk of Locoregional Recurrence in Node-Negative, Estrogen Receptor-Positive Breast Cancer[J]. Journal of Evidence-Based Medicine, 2010, 10(2): 77-79. DOI: 10.3969/j.issn.1671-5144.2010.02.010
|
Hu Xi-chun, GU Shi-yang, ZU Jian. Association between the 21-Gene Recurrence Score Assay and Risk of Locoregional Recurrence in Node-Negative, Estrogen Receptor-Positive Breast Cancer[J]. Journal of Evidence-Based Medicine, 2010, 10(2): 77-79. DOI: 10.3969/j.issn.1671-5144.2010.02.010
|
Citation:
|
Hu Xi-chun, GU Shi-yang, ZU Jian. Association between the 21-Gene Recurrence Score Assay and Risk of Locoregional Recurrence in Node-Negative, Estrogen Receptor-Positive Breast Cancer[J]. Journal of Evidence-Based Medicine, 2010, 10(2): 77-79. DOI: 10.3969/j.issn.1671-5144.2010.02.010
|
DownLoad: